Effects of blood pressure-lowering drugs in heart failure: a systematic review and meta-analysis of randomized controlled trials.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 6 4 2019
medline: 1 7 2020
entrez: 6 4 2019
Statut: ppublish

Résumé

: We aimed to combine evidence from all heart failure trials that have investigated the effects of drugs with blood pressure (BP)-lowering properties to assess the extent to which such drugs reduce BP in heart failure, the association between the net change in BP between treatment arms and cause-specific outcomes and whether treatment effects (efficacy and safety) vary according to baseline BP. We conducted a systematic review and meta-analysis including randomized clinical trials of drugs with BP-lowering properties in patients with chronic heart failure with at least 300 patient-years follow-up. We included a total of 37 trials (91 950 patients) and showed that treatment with drugs with BP-lowering properties resulted in a small but significant decrease in SBP in patients with heart failure with no evidence that the efficacy and safety of those drugs varied according to baseline BP.

Identifiants

pubmed: 30950980
doi: 10.1097/HJH.0000000000002094
doi:

Substances chimiques

Cardiovascular Agents 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1757-1767

Subventions

Organisme : Department of Health
ID : CDF-2015-08-074
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/19/64/34673
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/18/65/33872
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Auteurs

Ana-Catarina Pinho-Gomes (AC)

The George Institute for Global Health.
Deep Medicine, Oxford Martin School, University of Oxford.

Luis Azevedo (L)

Department of Community Medicine, Information and Health Decision Sciences, Centre for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal.

Zeinab Bidel (Z)

Collaboration Center of Meta-Analysis Research, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.

Milad Nazarzadeh (M)

The George Institute for Global Health.
Deep Medicine, Oxford Martin School, University of Oxford.

Dexter Canoy (D)

The George Institute for Global Health.
Deep Medicine, Oxford Martin School, University of Oxford.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford.

Emma Copland (E)

Deep Medicine, Oxford Martin School, University of Oxford.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford.

Abdul Salam (A)

The George Institute for Global Health, Hyderabad, Telangana, India.

Anthony Rodgers (A)

The George Institute for Global Health, University of New South Wales, Sidney, New South Wales, Australia.

Dipak Kotecha (D)

Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
Monash University Centre of Cardiovascular Research and Education, Melbourne, Victoria.

Kazem Rahimi (K)

The George Institute for Global Health.
Deep Medicine, Oxford Martin School, University of Oxford.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH